October 8, 2019 / 3:28 PM / 14 days ago

GSK recalls popular heartburn medicine Zantac - U.K. medicines watchdog

Oct 8 (Reuters) - GlaxoSmithKline Plc is recalling its heartburn medicine Zantac as a "precautionary measure" due to a probable cancer-causing impurity in the drug, Britain's medicines watchdog said on Tuesday.

GSK is recalling all unexpired stock of Zantac, also sold generically as ranitidine, from pharmacies as a precaution due to possible contamination with an impurity NDMA, which has genotoxic and carcinogenic potential, the Medicines and Healthcare products Regulatory Agency (MHRA) said here (Reporting by Justin George Varghese in Bengaluru; editing by Bill Berkrot)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below